Home > Financial Ratios > TTK HEALTHCARE

TTK HEALTHCARE
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for TTK HEALTHCARE
Please provide your vote to see the results

TTK HEALTHCARE Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 6.1525.42108.7630.47-21.08

What is the latest Core EBITDA Growth ratio of TTK HEALTHCARE ?

The latest Core EBITDA Growth ratio of TTK HEALTHCARE is 6.15 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar20256.15
Mar202425.42
Mar2023108.76
Mar202230.47
Mar2021-21.08

How is Core EBITDA Growth of TTK HEALTHCARE Trending?

Years Core EBITDA Growth % Change
Mar2025 6.15
-75.81
Mar2024 25.42
-76.63
Mar2023 108.76
256.94
Mar2022 30.47
Positive
Mar2021 -21.08 -

Other Financial Ratios of TTK HEALTHCARE


Compare Core EBITDA Growth ratio of peers of TTK HEALTHCARE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TTK HEALTHCARE ₹1,621.7 Cr -2.7% -1.7% -32.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹392,063.0 Cr 0.5% 4.6% -18.2% Stock Analytics
DIVIS LABORATORIES ₹155,749.0 Cr -3.2% -6.7% 4.4% Stock Analytics
CIPLA ₹122,429.0 Cr 0.3% -3.5% -10.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹118,928.0 Cr 0.9% -0.6% 3.5% Stock Analytics
DR REDDYS LABORATORIES ₹104,168.0 Cr -2.2% -0.9% -9.4% Stock Analytics


TTK HEALTHCARE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TTK HEALTHCARE

-2.7%

-1.7%

-32.5%

SENSEX

0.1%

1.3%

-5.1%


You may also like the below Video Courses